Clinical value of monoclonal antibodies and tyrosine kinase inhibitors in the treatment of head and neck squamous cell carcinoma
Crossref DOI link: https://doi.org/10.1007/s12032-017-0918-1
Published Online: 2017-03-17
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Blaszczak, Wiktoria
Barczak, Wojciech
Wegner, Anna
Golusinski, Wojciech
Suchorska, Wiktoria Maria
Funding for this research was provided by:
Narodowe Centrum Nauki (2015/17/N/NZ5/00686)
License valid from 2017-03-17